Start of Main Content
Faculty directory
Andrew Cittadine
A general manager, CEO, and serial entrepreneur with a successful track record of identifying, founding, and building healthcare technology businesses from concept to commercialization to acquisition by Fortune Global 1000 firms. These include founding two successful imaging companies, Sensant (Siemens), a 3D ultrasound business, and American BioOptics, an optical imaging startup acquired by a leading global endoscopy company. Andrew was also the startup CEO for SonarMed (Medtronic). He has overseen the successful execution of multi-center clinical trials for new technologies and secured regulatory clearances for new technologies in Europe (CE) and the US (FDA). Andrew is a co-founder and board member of MATTER, the Midwest’s leading healthcare startup incubator, community nexus, and corporate innovation center. He also serves on the board of the Hadley Institute, a non-profit providing learning opportunities that empower adults with vision loss or blindness. Andrew earned a BS and MS in Electrical Engineering and a BA in History from Stanford University, and an MBA from Kellogg.
NUVention: Medical Innovation II (HCAK-616-0)
**HCAK-615 can be a one-quarter course but is designed ideally as a two-quarter sequence in conjunction with HCAK-616**
NUvention Medical is designed as a two-term course to provide students with real-world experience as an innovator and entrepreneur in the rapidly evolving fields of health care devices and heath technology. Taught by a team of experienced healthcare entrepreneurs, innovators, and medical practitioners, the overall course goal is to develop an in-depth business plan, investor presentation, and viable product prototype for a new medical startup firm. To navigate the complex healthcare landscape, students form cross-disciplinary teams (including at least one student from Kellogg, Feinberg, McCormick, and Pritzker) to conceive of and identify an innovative new healthcare product and work to evaluate the opportunity with support from leading industry guest lecturers and direct mentoring from experience faculty advisors. In the fall term, COVID-permitting, student teams will shadow healthcare practitioners in the hospital to explore unmet market needs, work to understand important market opportunities from a risk-based perspective, use design thinking principles to conceive of an innovative product with a convincing value proposition, and explore many of the challenges facing health care including the regulatory and reimbursement environment. Teams then pitch their initial idea to active healthcare investors. In the winter term, the teams will work in depth to validate their customer and stakeholder assumptions, explore different revenue models, clearly understand the regulatory and reimbursement challenges and opportunities, define sales and distribution channels, and identify sources of capital. Each team is required to develop a full investor presentation backed up by a business plan and a viable prototype. Both the fall pitch and final winter investor presentation will be made to a group of experienced health care executives and investors. After the fall term, students will be given the choice of whether or not to continue into the winter term, and the faculty will decide which ideas are eligible to advance based on their business potential. All students with acceptable attendance and level of effort in the fall term will be permitted to continue whether their pitch idea advances or not, possibly necessitating some team modifications. Readings include text, industry articles and a few cases. Classes are held at the Law School (primarily fall), KGH (primarily winter), and the Ford design center. A number of classes will have healthcare industry leaders as guest speakers. Students are evaluated on the basis of both team and individual assignments with team assignments more heavily weighted. Grades will be awarded for each term separately. Permission from the student's school faculty representative is required to register. Students must complete the fall (I) quarter (HCAK 615) in order to be eligible for the winter (II) quarter (HCAK 616), and will earn 1.0 credit for each term completed. Students in the 2 Year Full Time program and the Evening & Weekend program must have completed one full year. Students in the 1 Year program need to have completed the summer quarter.NUVention: Medical Innovation I (HCAK-615-0)
**HCAK-615 can be a one-quarter course but is designed ideally as a two-quarter sequence in conjunction with HCAK-616**
NUvention Medical is designed as a two-term course to provide students with real-world experience as an innovator and entrepreneur in the rapidly evolving fields of health care devices and heath technology. Taught by a team of experienced healthcare entrepreneurs, innovators, and medical practitioners, the overall course goal is to develop an in-depth business plan, investor presentation, and viable product prototype for a new medical startup firm. To navigate the complex healthcare landscape, students form cross-disciplinary teams (including at least one student from Kellogg, Feinberg, McCormick, and Pritzker) to conceive of and identify an innovative new healthcare product and work to evaluate the opportunity with support from leading industry guest lecturers and direct mentoring from experience faculty advisors. In the fall term, COVID-permitting, student teams will shadow healthcare practitioners in the hospital to explore unmet market needs, work to understand important market opportunities from a risk-based perspective, use design thinking principles to conceive of an innovative product with a convincing value proposition, and explore many of the challenges facing health care including the regulatory and reimbursement environment. Teams then pitch their initial idea to active healthcare investors. In the winter term, the teams will work in depth to validate their customer and stakeholder assumptions, explore different revenue models, clearly understand the regulatory and reimbursement challenges and opportunities, define sales and distribution channels, and identify sources of capital. Each team is required to develop a full investor presentation backed up by a business plan and a viable prototype. Both the fall pitch and final winter investor presentation will be made to a group of experienced health care executives and investors. After the fall term, students will be given the choice of whether or not to continue into the winter term, and the faculty will decide which ideas are eligible to advance based on their business potential. All students with acceptable attendance and level of effort in the fall term will be permitted to continue whether their pitch idea advances or not, possibly necessitating some team modifications. Readings include text, industry articles and a few cases. Classes are held at the Law School (primarily fall), KGH (primarily winter), and the Ford design center. A number of classes will have healthcare industry leaders as guest speakers. Students are evaluated on the basis of both team and individual assignments with team assignments more heavily weighted. Grades will be awarded for each term separately. Permission from the student's school faculty representative is required to register. Students must complete the fall (I) quarter (HCAK 615) in order to be eligible for the winter (II) quarter (HCAK 616), and will earn 1.0 credit for each term completed. Students in the 2 Year Full Time program and the Evening & Weekend program must have completed one full year. Students in the 1 Year program need to have completed the summer quarter.